Globally, over 16 million peripheral vascular procedures were performed in 2020. The majority of these procedures were vascular closure device procedures followed by PTA balloon catheter procedures.

Globally, over 6 million cardiac surgery procedures were performed in 2020. The majority of these procedures were autotransfusion procedures followed by surgical heart valve procedures. Over the forecast period, all of the procedures included in this report are projected to experience growth, some faster than others, following COVID-19 headwinds. 

Atrial fibrillation (AF) is an abnormal heart rhythm. Patients with AF experience episodes of rapid and irregular beating. As a result of the irregular beating, the atrium in AF patients does not completely contract, impeding the flow of blood from the atria into the ventricles. Blood that is not expelled from the left atria collects in the sac-shaped LAA. Once in the LAA, the movement of the blood slows.

The global Heart Defects Closure Device Market Reportcontains analysis for Patent Foramen Ovale Closure Devices and Atrial & Ventricular Septal Defect Closure Devices. The global patent foramen ovale closure market and global atrial & ventricular septal defect closure markets are expected to reach $322.7M and $226.2M by 2027, respectively.

Of the four valves in the human heart (mitral valve, tricuspid valve, aortic valve and pulmonary valve), the mitral valve is most prone to regurgitation. This is a condition where blood is funneled back into the left atrium of the heart. Mitral regurgitation (MR) can either be caused by a congenital defect or myxomatous degeneration of the valve.

Surgical heart valve replacement procedures can be performed using tissue or mechanical heart valves. Tissue valve procedures can be classified by valve replaced (aortic, mitral, tricuspid or pulmonary), by material (xenograft or allograft) or device type (stented, sutureless or stentless). Mechanical valves can be classified by valve replaced (aortic, mitral, tricuspid or pulmonary) or by conduit (with conduit or without conduit).

Ventricular assist devices (VADs) are used to aid a failing heart by supplementing the pumping function of the heart. VADs are often used in patients with advanced heart failure (HF). HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pump power of the heart, which causes the heart to become too weak to pump blood at a level sufficient to meet the body’s demands.

Off-pump coronary artery bypass (OPCAB), or simply beating-heart coronary artery bypass grafting, uses a median sternotomy to access the heart, similar to on-pump coronary artery bypass (ONCAB) procedures. The important difference is that the cardiopulmonary bypass pump is not employed. Clinical studies show that OPCAB offers several benefits compared to ONCAB procedures, including reductions in bleeding, short-term neurocognitive dysfunction, kidney dysfunction and length of hospital stay.

The full report suite global market research spans over 70 countries providing details on the global market for surgical display and PACS monitors, including HD, 4K and 8-megapixel ultra high definition (UHD) surgical displays and PACS monitors.

Image management devices record video with almost no loss in resolution. Digital technology offers powerful editing capabilities without loss in resolution and quality. In addition, it backs up data eight times faster than older technologies and can retrieve files in seconds, as opposed to minutes.

The majority of the global microscope market share was controlled by Carl Zeiss, Leica Microsystems, and Alcon. This global market research spans over 70 countries and includes the ophthalmology/optometry microscope, neurosurgery/spine microscope, ENT microscope, and the plastic reconstructive surgery microscope markets.

The average lifespan of a surgical table is between 10 and 15 years. This encourages many facilities to continue using outdated models. Although new table models offer many convenient features, such as greater weight and width capacities, their functionality has essentially remained unchanged for the last 30 years.

The principles of operating room (OR) integration are based on concepts that were established in the late 1960s and early 1970s. Originally, the concept of an integrated OR consisted of a surgeon who would operate on a patient located on a central surgical table with all the necessary equipment available on mobile carts operated by nurses. However, the advancement of technology in the late 20^th century precipitated a change in the approach to OR integration.

The global access devices market size is expected to reach nearly $1.1 billion by 2026, with the single port access devices segment showing the highest growth. Currently, over one-third of the global market share is controlled by Applied Medical, Medtronic, and Ethicon. Laparoscopic access devices are used for puncturing the body to allow a laparoscope,

The global peripheral atherectomy devices market size is estimated to increase over the forecast period to exceed $1.1 billion in 2027. The global coronary atherectomy devices market size is expected to reach over $947.4 million in 2027. The majority of the global atherectomy device market share was controlled by Medtronic and Boston Scientific. Overall, this

In 2019, the global syringe and needle market size was valued at $6.8 billion, with the majority of the market size occupied by the needles segment. The global market size is set to expand partially due to the COVID19 pandemic and exceed $7.5 billion in 2026.  In North America and Europe, the majority of the